MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.
2015
MEK1 and MEK2 have key roles in tumorigenesis and, therefore, represent promising targets for cancer therapy. This Review discusses the mechanisms of action of different inhibitors of MEK1 and MEK2, the mechanisms of resistance to these inhibitors and their current clinical progress.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
200
References
334
Citations
NaN
KQI